A randomized, double blind, placebo-controlled crossover study to investigate the effects of a selective serotonergic reuptake inhibitor on resting state fMRI in healthy volunteers.
Phase of Trial: Phase II
Latest Information Update: 18 Mar 2015
At a glance
- Drugs Sertraline (Primary)
- Indications Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Post-traumatic stress disorders
- Focus Pharmacodynamics
- 18 Mar 2015 New trial record